For many years, various types of research are going on all over the world for better treatment of cancer. Now recently, through these research, scientists have got success in the field of cancer. Now another success has emerged. Actually, the treatment named ‘Theranostics’ has become a topic of discussion recently. Through this treatment, radioactive medicine is used to identify the cancerous tumor. During tumor treatment, other medicines are used in therapy.
AIIMS Hospital of Delhi has been doing research in this area for 15 years. So that the method of treatment of cancer patients can be improved. So that the age of patients increases. The hospital claims that the quality of life of patients has increased in two years.
What is this treatment
Professor and Head of Nuclear Medicine Department, Dr. CS Bal told in an interview to Times of India that in this treatment, the cancer patient will be removed by tagging. At the same time, it will not affect healthy tissues. The method of radiation is different in this. This therapy is used on patients who have no reason left after traditional cancer treatment fails.
How does this therapy work
The term theranostics is derived from observation and treatment. It deals with the concept of molecules labeled with radionuclides or radioisotopes. It has combined properties of selectivity of internal radiation and chemotherapy. This is the first method of treatment for chronic cancers like surgery, radiation and chemotherapy. In cases where cancer has spread to other organs, this medicine also controls it.
This is the best method for the treatment of many types of cancer
This therapy treats patients suffering from castration-immune prostate cancer, when testosterone levels fluctuate above the castration level. Its positive results are also seen in radioiodine-refractory thyroid cancer, neuroendocrine tumor, triple-negative breast cancer and medullary thyroid cancer.
Also read: Cure for many diseases is available in your home, this is the most effective home-made antibiotic.
Source link
